WHO to Resume Hydroxychloroquine Trial, Tedros Says

The video discusses the temporary pause of the Hydroxychloroquine arm in a trial due to safety concerns. After reviewing mortality data, the committee found no need to change the trial protocol. The trial will continue, including the Hydroxychloroquine arm, with ongoing safety monitoring. Over 3500 patients have been recruited across 35 countries. The organization is committed to advancing therapeutics, vaccines, and diagnostics.

What will the data safety and monitoring community continue to do in the solidarity trial?

What is W Joy's commitment in relation to therapeutics, vaccines, and diagnostics?